Subscribe To

Price Alert Latest News Economic Calendar News

BRKR / Bruker Corporation (BRKR) CEO Frank Laukien on Q2 2022 Results - Earnings Call Transcript

Bruker Corporation (NASDAQ:BRKR ) Q2 2022 Earnings Conference Call August 3, 2022 4:30 PM ET Company Participants Justin Ward - Senior Director of Investor Relations and Corporate Development Frank Laukien - Chairman, President and Chief Executive Officer Gerald Herman - Executive Vice President and Chief Financial Officer Conference Call Participants Derik De Bruin - Bank of America Merrill Lynch Puneet Souda - SVB Securities Brandon Couillard - Jefferies Jack Meehan - Nephron Research Josh Waldman - Cleveland Research Max Masucci - Cowen Rachel Vatnsdal - JPMorgan Operator Good day, and welcome to the Bruker's Second Quarter 2022 Earnings Conference Call. All participants will be in a listen-only mode. Read More

Demo Live Account See Partner Details

Content Topics

Bruker

Corporation

BRKR

Frank

Laukien

2022

Results

brkr

Earnings

Transcript

Stock

Posted: Aug 3 2022, 23:31

Author Name: Seeking Alpha

BRKR News

By Seeking Alpha
November 3, 2023

Bruker Corporation (BRKR) Q3 2023 Earnings Call Transcript

Bruker Corporation (NASDAQ:BRKR ) Q3 2023 Earnings Conference Call November 2, 2023 8:30 AM ET Company Participants Justin Ward - Investor Relations F

By Business Wire
October 27, 2023

Bruker Announces Date and Time of Third Quarter 2023 Earnings Release and Webcast

BILLERICA, Mass.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced it will report third quarter 2023 financial resul

By Zacks Investment Research
October 20, 2023

Will Bruker (BRKR) Beat Estimates Again in Its Next Earnings Report?

Bruker (BRKR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat i

By Zacks Investment Research
October 12, 2023

Here's Why Investors Should Buy Bruker (BRKR) Stock Now

The strong prospects of the BSI BioSpin and CALID group are likely to bode well for Bruker (BRKR) stock.

By Zacks Investment Research
October 5, 2023

Bruker (BRKR) Becomes Majority Investor in MIRO Analytical AG

Bruker's (BRKR) majority investment in MIRO adds state-of-the-art QCL technology to the Bruker Optics gas-analysis portfolio.

By Zacks Investment Research
October 4, 2023

Bruker (BRKR) Introduces the New Hysitron TI 990 TriboIndenter

Bruker's (BRKR) TI 990 is a comprehensive advancement of its industry-leading TriboIndenter platform.

By Zacks Investment Research
September 19, 2023

Bruker (BRKR) Advances Novel 4D-Proteomics Capabilities

Bruker's (BRKR) commitment to innovation and customer support makes it a great partner and helps achieve its mission of translating nature into medici

By Zacks Investment Research
September 12, 2023

Bruker (BRKR) Inks Fraport Framework Contract for ETD Systems

Bruker's (BRKR) DE-tector flex system uses a non-radioactive ionization source and is approved by national regulatory bodies and ECAC.

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.